Bio-Connect

Mouse anti Human Fibronectin

Research Use Only
X1263M
Nordic-MUbio
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse
TargetFN1
Price on request
100 ug
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Nordic-MUbio
  • Product Name
    Mouse anti Human Fibronectin
  • Delivery Days Customer
    7
  • Application Supplier Note
    Antibody can be used for staining of human and mouse frozen and paraffin-embedded tissue sections. Optimal concentration should be evaluated by serial dilutions.
  • Applications
    ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Applications Supplier
    Immunohistochemistry (frozen & paraffin)
  • Category Supplier
    Primary antibodies
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    EP5
  • Conjugate
    Unconjugated
  • Gene ID2335
  • Target name
    FN1
  • Target description
    fibronectin 1
  • Target synonyms
    CIG; cold-insoluble globulin; ED-B; epididymis secretory sperm binding protein; fibronectin; FINC; FN; FNZ; GFND; GFND2; LETS; migration-stimulating factor; MSF; SMDCF
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDP02751
  • Protein Name
    Fibronectin
  • Scientific Description
    Fibronectin
  • Shelf life instruction
    See expiration date on vial
  • Source
    Hybridoma produced by the fusion of splenocytes from BALB/c mice immunized with T-cell lymphoma biopsy and mouse myeloma cells.
  • Reactivity
    Human, Mouse
  • Reactivity Supplier
    Human;Mouse
  • UNSPSC
    12352203

References

  • 1. Van Vliet, A., et al. Distribution of fibronectin isoforms in human renal disease. J. Pathol. 2001, 193, 256-262. 2. Athanassiadou, P., et al., Moc-31, fibronectin and CEA in the differential diagnosis of malignant effusions: an immunocytochemical study. Pathol. Oncol. Res. 2000, 6, 100-103. 3. Menzin, A.W., et al. Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: detection in ascitic fluid and localization to primary sites and metastatic implants. Cancer 1998, 82, 152-158.